BioCardia terminates Lincoln Park equity line, lifts Cantor ATM suspension

BioCardia, Inc.

Terminated Purchase Agreement with Lincoln Park Capital effective July 3, 2023; no further share sales allowed.
Resumes sales under Cantor Fitzgerald Controlled Equity Offering Sales Agreement dated April 12, 2022.
Financing shift: replaces existing equity line with ATM facility for future capital raises.

item 1.02 item 8.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

BioCardia, Inc. terminated Purchase Agreement with Lincoln Park Capital Fund, LLC (effective 2023-06-30).

Action: termination
Agreement: equity purchase
Counterparty: Lincoln Park Capital Fund, LLC
Effective: 2023-06-30

Exact text from the filing

On June 30, 2023, BioCardia, Inc. (the “Company”), provided notice to Lincoln Park Capital Fund, LLC of its election to terminate the Purchase Agreement between them dated March 29, 2021 (the “Purchase Agreement”).

View on SEC.gov

Browse all material agreements →

BioCardia, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-23-018959

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.